RxSight Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$22.2M
Doctors Paid
8,158
Transactions
20,459
2024 Total
$12.3M
Payment Breakdown by Category
Research$7.1M (32.1%)
Consulting$3.3M (14.9%)
Food & Beverage$927,095 (4.2%)
Travel$17,871 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10.7M | 31 | 48.2% |
| Unspecified | $7.1M | 2,330 | 32.1% |
| Consulting Fee | $3.3M | 571 | 14.9% |
| Food and Beverage | $927,095 | 16,741 | 4.2% |
| Education | $55,766 | 53 | 0.3% |
| Gift | $50,258 | 130 | 0.2% |
| Travel and Lodging | $17,871 | 36 | 0.1% |
| Honoraria | $15,283 | 561 | 0.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,000 | 1 | 0.0% |
| Entertainment | $697.11 | 5 | 0.0% |
Payments by Type
General
$15.0M
18,129 transactions
Research
$7.1M
2,261 transactions
Ownership
$0
69 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | $5.1M | 34 | 2,032 |
| CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE RXSIGHT LIGHT ADJUSTABLE LENS (LAL) IN SUBJECTS DESIRING AN EXTENDED DEPTH OF FOCUS | $1.3M | 15 | 141 |
| Clinical Outcomes of Patients Bilaterally Implanted with the Commercially Available RxSight Light Adjustable Lens (LAL) | $480,500 | 0 | 38 |
| Clinical Outcomes of Patients Implanted with the Commercially Available RxSight Light Adjustable Lens (LAL) | $61,300 | 0 | 17 |
| BINOCULAR CUSTOM VISION UTILIZING THE LIGHT ADJUSTABLE LENS (LAL) | $42,915 | 1 | 1 |
| Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery | $31,948 | 13 | 25 |
| CLINICAL OUTCOMES OF PATIENTS IMPLANTED WITH THE RXSIGHT LIGHT ADJUSTABLE LENS (LAL) | $11,200 | 3 | 3 |
| CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF PERFORMING 0.50 DIOPTER ASTIGMATISM CORRECTION ON THE COMMERCIALLY AVAILABLE RXSIGHT LIGHT ADJUSTABLE LENS (LAL) | $9,700 | 2 | 3 |
| ActiveShield US Data Collection PMCS-002 | $3,461 | 1 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 7
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Jack Tian, M.d, M.D | Ophthalmology | Seattle, WA | $2,799 | $0 |
| Dr. Leiv Takle, Md, MD | Ophthalmology | Griffin, GA | $2,791 | $0 |
| Amanda Hoelscher, Od, OD | Optometrist | Dallas, TX | $2,770 | $0 |
| Dr. Alex Liu, O.d, O.D | Optometrist | Rowland Heights, CA | $2,550 | $0 |
| Claude Bundrick, Md, MD | Ophthalmology | Shreveport, LA | $2,504 | $0 |
| Dr. Samir Melki, M.d., Phd, M.D., PHD | Ophthalmology | Brookline, MA | $2,496 | $0 |
| Dr. Jessica Hults, Od, OD | Optometrist | Indianapolis, IN | $2,431 | $0 |
| Dr. Loren Rude, O.d, O.D | Optometrist | Long Beach, CA | $2,377 | $0 |
| Lorraine Provencher, M.d, M.D | Ophthalmology | Omaha, NE | $2,331 | $0 |
| Dr. Richard Davis, Md, MD | Ophthalmology | Fort Myers, FL | $2,276 | $0 |
| Dr. Andrew Caster, M.d, M.D | Ophthalmology | Beverly Hills, CA | $2,252 | $0 |
| Jamie Monroe, Md, MD | Ophthalmology | Orem, UT | $2,251 | $0 |
| Leland Rosenblum, M.d, M.D | Ophthalmology | Monterey, CA | $2,235 | $0 |
| Bryan Lusk, M.d, M.D | Ophthalmology | Shreveport, LA | $2,217 | $0 |
| Centrael Evans, Md, MD | Glaucoma Specialist | Athens, GA | $2,137 | $0 |
| Anna Shi, M.d, M.D | Ophthalmology | Monterey, CA | $2,095 | $0 |
| Dr. Jeff Banas, Od, OD | Optometrist | Mount Pleasant, WI | $2,090 | $0 |
| Dr. Brian Shafer, M.d, M.D | Cornea and External Diseases Specialist | Plymouth Meeting, PA | $2,022 | $0 |
| Randy Kardon, Md Ph D, MD PH D | Neuro-ophthalmology | Iowa City, IA | $2,000 | $0 |
| Ashley Owyang, O.d, O.D | Optometrist | Long Beach, CA | $1,974 | $0 |
| Dr. Mark Pyfer, M.d, M.D | Ophthalmology | Jenkintown, PA | $1,909 | $0 |
| Preston Sullivan, Md, MD | Ophthalmology | Gig Harbor, WA | $1,867 | $0 |
| Don Minckler, Md, MD | Anatomic Pathology | Orange, CA | $1,845 | $0 |
| Dr. Omar Shakir, Md Mba, MD MBA | Ophthalmology | Greenwich, CT | $1,835 | $0 |
| Ann Buikema Wiarda, Md, MD | Ophthalmology | Warsaw, IN | $1,826 | $0 |
Ad
Top Products
- RXSIGHT CONTACT LENS $16.0M
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) $5.8M
Associated Products (4)
Payment Categories
- Food & Beverage $927,095
- Consulting $3.3M
- Travel & Lodging $17,871
- Research $7.1M
About RxSight Inc
RxSight Inc has made $22.2M in payments to 8,158 healthcare providers, recorded across 20,459 transactions in the CMS Open Payments database. In 2024, the company paid $12.3M. The top product by payment volume is RXSIGHT CONTACT LENS ($16.0M).
Payments were distributed across 69 medical specialties. The top specialty by payment amount is Ophthalmology ($15.0M to 3,557 doctors).
Payment categories include: Food & Beverage ($927,095), Consulting ($3.3M), Research ($7.1M), Travel & Lodging ($17,871).
RxSight Inc is associated with 4 products in the CMS Open Payments database, including RXSIGHT CONTACT LENS, LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD), and RXSIGHT INJECTOR HANDPIECE.